CEO of Cytosorbents Phillip Chan Discusses The Company’s Earnings Report
FDA Gives Cytosorbents’ blood purification technology emergency authorization
CytoSorbents CEO Dr. Phillip Chan on The Street, discussing how CytoSorbents flagship treatment CytoSorb has been used to treat 65 patients in China as well as in Italy with COVID-19 infection.
CytoSorbents CEO Dr. Phillip Chan live on Fox Business with Liz Claman discussing how CytoSorbents flagship treatment CytoSorb may help treat complications of coronavirus infection and initial CytoSorb treatments of patients in China and Italy.
“Cytosorbents CEO on How to Avoid the Flu and Cytokine Storms”
TradeTalks: “Brita for Blood” Fights Complications from the Flu